跳至主要内容
临床试验/JPRN-C000000236
JPRN-C000000236未知未知

Clinical study to investigate the effects of olmesartan and azelnidipine in patients with hypertesnion and arteriosclerosis obliterans - Clinical study to investigate the effects of olmesartan and azelnidipine in patients with hypertesnion and arteriosclerosis obliterans

Cardiovascular Hospital of Central Japan0 个研究点目标入组 60 人开始时间: 2008年1月1日最近更新:
适应症

试验速览

阶段
未知
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) Fontane classification III or IV 2) Immediate requirement for surgical operation 3) Myocardial infarction, unstable angina pectoris, stroke or transient ischemic atttack within 6 months before giving informed consent 4) Deep-vein thrombosis within 3 months before giving informed consent 5) Malignancy that requires treatment 6) Liver dysfunction (AST and ALT>100IU/L) 7) Renal dysfunction (creatinine>3.0mg/dL)

研究者

发起方
Cardiovascular Hospital of Central Japan

相似试验